Deficiency of the apoptosome component Apaf1 leads to accumulation of supernumerary brain cells in mouse embryos. We observed that neural precursor cells (NPCs) in Apaf1 À/À embryos escape programmed cell death, proliferate and retain their potential to differentiate. To evaluate the circumstances of Apaf1 À/À NPC survival and investigate their fate under neurodegenerative conditions, we established cell lines of embryonic origin (ETNA). We found that Apaf1 À/À NPCs resist common apoptotic stimuli and neurodegenerative inducers such as amyloid-b peptide (typical of Alzheimer's disease) and mutant G93A superoxide dismutase 1 (typical of familial amyotrophic lateral sclerosis). Similar results were obtained in Apaf1 À/À primary cells. When death is prevented by Apaf1 deficiency, cytochrome c is released from mitochondria and rapidly degraded by the proteasome, but mitochondria remain intact. Under these conditions, neither activation by cleavage of initiator caspases nor release of alternative apoptotic inducers from mitochondria takes place. In addition, NPCs can still differentiate, as revealed by neurite outgrowth and expression of differentiation markers. Our findings imply that the mitochondrion/apoptosome pathway is the main route of proneural and neural cells to death and that its inhibition prevents them from dismantling in neurodegenerative conditions. Indeed, the ETNA cell model is ideally suited for exploring the potential of novel cell therapies for the treatment of human neurodegenerations.
Introduction
The apoptosome is a large molecular complex operating as an engine of caspase activation that, in turn, initiates and/or executes apoptosis. 1 Apaf1 is a scaffold protein participating in apoptosome formation in mammals.
2 Apaf1 and the apoptosome are involved in many aspects of mouse development, regulated by morphogenetic, histogenetic and phylogenetic apoptosis. [3] [4] [5] In particular, Apaf1 deficiency leads to brain hyperplasia, possibly due to accumulation of neural precursor cells (NPCs) that escape death and retain their potential to proliferate. 6 This phenotype is highly similar to Caspase-3 (Casp3) and Casp9 knockout phenotypes. It is widely believed that activation of the apoptosome, followed by Casp9 and Casp3 activation, plays a central role in cell death in the nervous system. 7 This pathway of death is distinct from those occurring in other embryonic tissues, such as the immune system 8 and the haematopoietic system, where Casp2 activation seems to be more relevant and the apoptosome-mediated pathway represents a mere amplification loop. 9 Moreover, in the brain, cell death is not simply a mechanism to match the neuron population to its target fields. Rather, cell death plays an additional and important role in adjusting the initial progenitor pool needed for proper morphogenesis of the nervous system, the mechanism of which is still to be investigated. Based on the preliminary finding that Apaf1 À/À neuroepithelium proliferates in vivo for a few days of embryonic life and then starts to differentiate, we established cell lines of embryonic origin, which express or lack Apaf1 and show several features of bona fide NPCs. To shed more light on Apaf1 À/À NPC circumstances of survival and fate, we applied several death inducers to them and checked if cells which escape death are still able to differentiate properly. Additionally, we extended the analysis to other developing CNS cell types, obtaining comparable results. Amid the various death stimuli we used, amyloid-b peptide (Ab) and a mutant form of superoxide dismutase 1 (G93A-SOD1) are particularly significant. In fact, inappropriate activation of apoptotic pathways mediated by these stimuli is a contributing event in two neurodegenerative diseases, Alzheimer's disease (AD) and familial amyotrophic lateral sclerosis (fALS). 7, 10 The two stimuli are very different: Ab forms aggregate and lead mainly to an extracellular death induction, while mutant SOD1 acts at the intracellular level. Furthermore, the stimuli's neuronal targets in adult life are different, since hippocampal, striatal, cortical and cerebellar neurons are typically affected in AD, whereas motor neurons are selectively affected in fALS.
Results
The Embryonic Telencephalic Naïve Apaf1 (ETNA) cells represent a model to study the behaviour of NPCs
We analysed cell proliferation in the neural tube of Apaf1 À/À and wild-type (wt) littermate embryos at embryonic day 12. 5 (e12.5) and found that mutant embryos showed a proliferation index twice as high as wt littermates in the rostral part of the neural tube [74.973.9 and 37.273.6% (forebrain), 28 .374.1% and 26.173.0% (hindbrain), respectively; see Figure 1a ]. We then checked mutant embryos at a later stage (e13.5-e14) for expression of proneural markers such as nestin, delta1, notch1, or a later marker of nerve cells (class III b-tubulin). We found that they were all expressed in conserved domains even when the cyto-architecture of the brain structure was profoundly disturbed (Figure 1b ). We observed a high level of nestin mRNA expression in the mutant neuroepithelium at e14, indicating the presence of progenitor cells. 11 For this reason, we decided to establish cell lines from the striatum primordia isolated from e14 wt and mutant embryos. This makes it possible to overcome problems occurring when using primary cultures, ranging from the heterogeneity of primary progenitor populations to the small amount of cells obtained with that method. Cells were infected with a retrovirus transducing the tsA58/U19 Large T Antigen and selected. 12 Cell lines derived in this manner are grown at 331C (permissive temperature) and contain a normal complement of chromosomes without contamination from a neuroblastoma line, this being a 
and ETNA À/À (À/À) cell lines were isolated from e14 wt and mutant embryos, respectively, and immortalized with a retrovirus transducing the tsA58/U19 large T antigen. Total extracts from both cell lines were immunoprecipitated with an anti-Apaf1 rabbit polyclonal antibody and analysed with a rat monoclonal antibody anti-Apaf1. Ctrl: human neuroblastoma cells (SH-SY5Y) stably overexpressing Apaf1. (d) Total cell lysates from ETNA þ / þ and ETNA À/À cells, either naïve (N) or incubated for 48 h with a differentiation medium (D), were analysed by Western blotting for the expression of NeuN, class III b-tubulin, ChAT, PSD95, tau; b-actin was also assayed as a control of equal protein loading. (e) ETNA þ / þ and ETNA À/À cells, either naïve or differentiated, were immunostained with an antibody recognizing the 160 kDa form of neurofilament (NF-M). Scale bar: 40 mm Escaping apoptosis in neurodegeneration M Cozzolino et al consequence of the somatic fusion strategy. 13 After appropriate selection, several surviving cell clones were picked and named Embryonic Telencephalic Naïve Apaf1 (ETNA)
and ETNA À/À cells, respectively ( Figure 1c ). Analysis of all clones gave consistent results: data from clones NDR1 (ETNA þ / þ ) and ADR5 (ETNA À/À ) are shown. When induced to differentiate, both ETNA þ / þ and ETNA À/À cells displayed neurite outgrowth and the upregulation of some neural markers, such as choline acetyltransferase (ChAT) and class III b-tubulin (bIII-tubulin) (Figure 1d, e) .
ETNA
À/À cells resist several death stimuli
Cell death was induced in ETNA þ / þ and ETNA À/À cells by means of several common proapoptotic stimuli, such as staurosporine (STS), serum starvation (not shown) and transcriptional inhibition (actinomycin D, Act D). As a result of all these stimuli, ETNA þ / þ cells died within a few hours, as revealed by nuclear condensation, DNA fragmentation, cleavage of poly ADP ribose polymerase (PARP) and phosphatidylserine exposure, while ETNA À/À cells were clearly resistant to all assayed stimuli (Figure 2a, c, e) . Few, if any, apoptotic cells were observed in the several optical fields analysed. This behaviour of ETNA À/À cells could be recapitulated in ETNA þ / þ cells by treating them with zVAD-fmk, a wide-range caspase inhibitor (Figure 2b) . In order to verify the activity of Casp3 in ETNA þ / þ cells, its capacity to bind a fluoresecent substrate was tested; we observed that Casp3 is indeed involved in ETNA cell death (Figure 2d ). 
þ / þ and ETNA À/À cells were then exposed to neurodegenerative stimuli typical of AD and fALS. First, we checked for apoptotic signals upstream of Apaf1. Upon induction of cell death, cytochrome c is released from the mitochondria, binds to Apaf1 and activates the apoptosome. At 72 h after Ab treatment, cytochrome c was released from the mitochondria of both ETNA þ / þ and ETNA À/À cells ( Figure 3 ). As a consequence of apoptosome formation, Casp3 was activated and death occurred in ETNA þ / þ cells (Figures 2 and  3) . In contrast, Casp3 activation and apoptotic death did not follow cytochrome c release in the absence of Apaf1 (ETNA À/À cells) (Figures 2 and 3 ). Cells transfected with the G93A mutant form of SOD1, SOD1 mutant forms being the cause of 20% of fALS cases, 14 followed a similar pathway. Cytochrome c was released in both ETNA þ / þ and ETNA À/À cells, while Casp3 activation and apoptotic death took place only in ETNA (Figures 2 and 3) . As a control, wtSOD1 transfected in parallel was unable to cause cell death in both cell lines (Figures 2 and 3) . In some experiments, the green fluorescent protein (GFP) was used as a reporter of both wild-type and G93A-SOD1 expression (see Materials and Methods).
The protection of ETNA À/À cells from death is solely due to the Apaf1 deficiency In order to demonstrate that the protection from death observed in ETNA À/À cells under several stimuli was a monogenic phenotype, we transformed them with a construct carrying the Apaf1 cDNA under the control of the strong constitutive promoter CAGGs. ETNA À/À cells transfected with Apaf1 cDNA were sensitive to death induced by STS, Act D, Ab and transfected G93A-SOD1 (Figure 4a, b) , as revealed by Casp3 activation and nuclear condensation. In addition to the genetic complementation experiment, we also analysed the cells after inactivation of the tsA58/U19 Large T Antigen gene expression by shifting the growth temperature from 33 to 391C (nonpermissive) (Figure  4c, d ). This was done to verify that the viral gene expression was not responsible for the observed phenotype. In fact, ETNA À/À cells at 391C resist apoptotic induction with all the applied stimuli. In conclusion, we were able to link the observed phenotype to Apaf1 deficiency only in the cell clones analysed. The main route of ETNA cells to death is along the mitochondrion/apoptosome pathway In order to better understand which caspases participate in the apoptosome-mediated death pathway in ETNA cells, we analysed the involvement of Casp9 by means of a specific inhibitor. The activation of Casp8 and Casp2 was also assessed by determining the cleaved forms of the respective pro-enzymes in Western blots. Casp9 was activated, consistently with Casp3 cleavage described above, upon G93A-SOD1 ( Figure 5a ) and Ab (not shown) stimuli. In contrast, Casp2 was not cleaved in this system, differing from what observed in the haematopoietic system and in transformed fibroblasts, where Casp2 plays a role upstream of the apoptosome 9,15 ( Figure 5b ). Similarly, Casp8 also remained uncleaved upon G93A-SOD1 or Ab treatment, although its expression levels were substantially increased with the latter stimulus ( Figure 5b ). Modulation of pro-Casp8 expression without significant cleavage was previously shown as a hallmark of severe traumatic head injury in humans. 16 Together, these results demonstrate a pivotal role for the apoptosomemediated pathway in cell death induced by neurodegenerative stimuli.
ETNA cells apoptosis induced by neurodegenerative stimuli is caspase-dependent and AIF-and EndoG-independent
Next, we followed the fate of Ab-treated and G93A-SOD1-overexpressing ETNA À/À cells that do not undergo apoptosis due to the absence of Apaf1. It has been suggested that, when caspases are inhibited, other factors, released from mitochondria in a caspase-independent manner, can trigger a secondary nonapoptotic form of death. 17 Apoptosis-inducing factor (AIF 18 ) has been related to a nonapoptotic morphotype in several cell types and conditions, for example, Apaf1 À/À interdigital web cells 19 and primary hippocampal neurons. 20 More recently, the independence of AIF release from caspase activation has been questioned. 21, 22 We found that AIF continued to remain in the mitochondrial compartment upon neurodegenerative stimuli in ETNA cells 72 h after G93A-SOD1 transfection or 96 h after Ab application (Figure 6a, b) , both in the presence and absence of apoptosome. Similarly, when cytochrome c was released in ETNA cells, the Endonuclease G (EndoG), a factor also known to trigger a caspase-independent type of death, 23 was retained in the mitochondria and did not contribute to any delayed forms of cell death (Figure 6c ). Release of both AIF and EndoG from 
ETNA
À/À cells mitochondria remain intact after cytochrome c release induced by neurodegenerative stimuli
At this point, we analysed whether mitochondria remain intact in ETNA þ / þ and ETNA À/À cells induced to die by G93A-SOD1 transfection and Ab treatment. We evaluated the effect of apoptosome inactivation on mitochondrial transmembrane potential (Dcm) by means of two reagents: CM-H 2 XROS and tetramethylrhodamine ethyl ester (TMRE). Both reagents, when added to the culture medium, can enter exclusively intact mitochondria in a voltage-dependent manner, and can be revealed by fluorescence. Apaf1 deficiency protected ETNA cells from the loss of mitochondrial potential (Figure 7a , b), as revealed by fluorescence localization and measurement, using the ETNA þ / þ cells as positive control and valinomycin-treated cells as a standard of strong Dcm dissipation. To analyse the mitochondrial capability for energy production, ATP concentration in ETNA cells exposed to Figure 5 The apoptosome pathway is the main route of ETNA cells to death. (a) ETNA þ / þ and ETNA À/À cells were transiently transfected with G93A-SOD1 in the absence or in the presence of 100 mM zLEHD-fmk, a specific inhibitor of Casp9. TUNEL assay and Hoechst staining were performed 48 h after transfection. The same representative field is shown here. Scale bar: 20 mm. Histogram represents the mean 7SD of three independent experiments. In all, 100 cells were analysed in three randomly chosen fields. (b) Total cell lysates from ETNA þ / þ and ETNA À/À cells untreated (ctrl), treated for 72 h with 50 mM Ab or 24 h after transfection with an unrelated plasmid (mock) or G93A-SOD1, were subjected to SDS-PAGE and analysed for Casp3, Casp2 and Casp8 processing. WtSOD1 or G93A-SOD1 transfected cells were also analysed for SOD1 expression. mSOD1: endogenous mouse SOD1; hSOD1: transfected human SOD1. Casp8 antibody sensitivity was assessed in CEM cells treated with 250 ng/ml of anti-Fas antibody (Upstate biotechnology) for the indicated times 24, 25 We then performed a morphological analysis of ETNA cells upon G93A-SOD1 death induction by EM (Figure 7d ). Most ETNA þ / þ cells transfected with G93A-SOD1 showed extensive mitochondrial damage with disarray of the cristae, as well as aspects of severe cytoplasmic degeneration and chromatin damage. Similar degenerative aspects were also seen in a few ETNA À/À cells. However, these cells mostly resembled nontransfected controls in their cytoplasmic and nuclear ultrastructure, suggesting again that apoptosome inhibition has the potential to protect cells from mitochondrial degeneration (Figure 7d ).
After release from mitochondria, cytochrome c is degraded by the proteasome in ETNA À/À cells escaping death
In order to follow the fate of cytochrome c, once it has been released from the mitochondria in the surviving ETNA À/À cells, we also analysed its levels in cell compartments after the application of death stimuli. We chose STS and Act D, since they are capable of rapidly inducing apoptosis in the vast majority of treated cells. Upon these stimuli, cytochrome c is released from the mitochondria and then degraded (Figure 8a,b) . The degradation is carried out by the 
À/À cells induced to die by neurodegenerative stimuli can still differentiate Finally, we analysed whether ETNA À/À cells induced to die by neurodegenerative stimuli retain their potential to differentiate. Ab-treated (120 h) or G93A-SOD1-GFP-transfected (48 h) cells were exposed to differentiating conditions (48 h in differentiating medium). Ab treatment could not be followed at a single-cell level, while transfected cells were detectable because of GFP fluorescence. After 120 h of Ab treatment, many surviving ETNA À/À cells differentiated (as shown by neurite outgrowth from cells showing cytochrome c release; Figure 9a ). Similarly, 96 h after G93A-SOD1-GFP transfection, about 70% of GFP-positive ETNA þ / þ cells died, whereas about 70% of GFP-positive ETNA À/À cells survived and differentiated (Figure 9b ). Due to the latter stimulus, when left in culture for an additional 48 h [total timeframe: 144 h (6 days)], transfected ETNA À/À cells eventually died with a phenotype characterized by massive overproduction and intracellular accumulation of G93A-SOD1-GFP (not shown).
In conclusion, cells that escape death induced by neurodegenerative stimuli are able to differentiate and maintain a sustainable lifespan until aggregates or inclusions induce a dramatic cellular collapse.
Apaf1
À/À primary cortical cells behave similarly to ETNA À/À cells when induced to die by several death stimuli
In order to further exclude a clonal specificity of the observed cellular phenotypes and to extend the analysis to other developing CNS cell types, we applied several death stimuli to primary cortical cells from Apaf1 À/À and wt littermate dissected brains (e14). Wt primary cells, upon induction by Act D, Ab and STS, underwent death by cytochrome c release, Casp3 activation and nuclear condensation, as expected (Figure 10a, b) . In contrast, Apaf1 À/À primary cells from cortical primordia do not show Casp3 activation induced by the same stimuli after several hours from the treatment and after release of cytochrome c. We could not test the G93A- 
Discussion
In this work, we have followed the fate of embryonic or embryonic-derived cells in vivo and in vitro, where cell death has been induced by developmental, stress-related and neurodegenerative stimuli in the presence or absence of the apoptosome. To date, Apaf1 and the apoptosome have been related to developmental cell death in the nervous system, eye, limbs, inner ear, craniofacial structures [3] [4] [5] and in several pathological conditions, such as malignant melanoma, prostate cancer and leukaemia. 26 The ability of Apaf1-, Casp9-or Casp3-knockout brains to overgrow was previously reported. 3, 4 Apaf1 involvement in brain-mass control in a dosage-dependent manner was also confirmed by the analysis of the hypomorphic mutant fog (forebrain overgrowth), in which Apaf1 levels are strongly reduced. 27 We wondered whether Apaf1 is involved in the main route of NPCs to death, as suggested by the knockout mouse phenotype, and whether the path to death could be somehow prevented or reverted in Apaf1 À/À cells. Additionally, we wanted to know what was the quality of surviving Apaf1 À/À cells committed to die, and whether they retained their potential to differentiate.
Our results here suggest that (i) NPCs are able to die predominantly, if not exclusively, by means of the mitochondrion-apoptosome pathway during development; (ii) cell lines derived from NPCs behave similarly when induced to die by several stimuli, including neurodegenerative ones; (iii) cytochrome c release from mitochondria is not a 'point of no return' in the NPC death pathway, since mitochondria on the verge of disruption do not lose their Dcm unless downstream steps of the apoptotic program are executed; however, cytochrome c becomes degraded by the proteasome after release; (iv) ETNA À/À cells escaping death, similarly to NPCs in vivo, are able to differentiate; (v) all the observed phenotypes are From e12 onwards, the brain of Apaf1 À/À embryos shows severe morphological distortions. A huge brain overgrowth, due to an enlargement of proliferative zones, is observed as a bilateral protrusion of the forebrain or as an exencephalic brain mass. Basically, three cell populations die during neural development: neuronal precursors, glial cells and postmitotic neurons. Our findings confirm that an apoptosome-dependent death regulates the size of NPC pools. This is certainly not the case in other regions of the developing organism. For instance, Apaf1 À/À thymocytes have been shown to be normally susceptible to Fas-mediated cell death, demonstrating that Apaf1 is dispensable for the Fas-mediated apoptotic pathways in thymocytes, involving Casp8 as an initiator caspase. 4 More recently, we reported that caspase activity is still discernible in embryonic haematopoietic cells lacking Apaf1 or Casp9, and that a Casp2 antagonist both inhibits apoptosis and retards cytochrome c release. 9 This Casp2-dependent caspase activation program acts independently of the cytochrome c/Apaf1/Casp9 apoptosome, which seems to amplify rather than initiate the caspase cascade. This seems to be the case also in human tumor cell lines, where cytotoxic stress was shown to cause activation of Casp2, required for mitochondria permeabilization. 15 We conclude that the main death pathways may vary among cell types in development and that a Casp8-, Casp2-dependent or nonapoptotic pathway of death is unlikely to occur or cannot compensate for the apoptosome in NPCs. This is in line with the absolute preponderance of the nervous phenotype in Apaf1-, Casp9-and Casp3-knockout mice.
We observed that, in ETNA cells, Casp8 expression is upregulated upon neurodegenerative stimuli, as happens in human brain after acute injury, as reported by others. 16 In this work, the authors showed that induction, upregulation and proteolysis of Casp8 occurs in human brain after trauma, and that relative Casp8 levels are associated with levels of Fas. Although cleavage of Casp8 was undetectable in both ETNA cell clones, our evidence suggests that Casp8 may be involved in the apoptotic response to neurodegenerative stimuli, but strictly in an apoptosome-dependent way.
We also observed that Casp2 expression levels in ETNA À/À cells were lower than in ETNA þ / þ cells. We cannot exclude that Casp2 expression might be downregulated in a given cell clone, since a slightly different panel of markers might be expressed in independent clones at a given step of differentiation. However, activation of Casp2 was undetectable in both ETNA cell clones. It should be mentioned that Abmediated death requires Casp2 in hippocampal neurons, sympathetic neurons and PC12 cells, 28 and requires Casp12 in primary cortical neurons. 29 This suggests that different pathways of death can be activated in different neuronal cell types. Since we showed the Apaf1 dependence of the Ab death pathway also in this cell culture system, our results argue for an epistatic relationship between the apoptosome activation and Casp12 under these conditions.
In addition to HeLa cells, which have been shown to recover from cytochrome c release during apoptosis upon inhibition of caspases, 24, 25 the definition of cytochrome c release as a 'point of no return' during cell death commitment in the nervous system has been previously confuted. Survival was observed in sympathetic neurons induced to die and deprived of apoptosome or caspase activity upon treatment with the trophic factor NGF. This factor seemed to induce de novo synthesis of protein in order to restore the mitochondrial pool of cytochrome c. 30 In the absence of this treatment, vice versa, cells were secondarily committed to die (25 h later) by a nonapoptotic mechanism. 31 
ETNA
À/À cells, however, seem to behave differently, surviving in normal growth condition (-NGF) for a period six times longer than 25 h and exhibiting properties of normal NPCs in culture. However, we show here that cytochrome c in these conditions is rapidly degraded by the proteasome. This could be due to the fact that, in contrast to NGF deprivation which could be reverted by simply adding NGF to the medium, other stimuli exert irreversible signals that cannot be removed and probably cause mitochondria to release cytochrome c persistently. This would happen even in the case that cytochrome c is newly synthesized and uptaken by the mitochondria: cytochrome c could be uptaken, released and degraded in a continuous loop. It would be interesting to investigate which bioenergetical pathways the maintenance of ATP concentration is based on, since it is conceivable that mitochondria deprived of cytochrome c cannot perform oxidative phosphorylation properly. As hypothesized elsewhere, 32 the best candidate to play this role is, without doubt, the glycolytic pathway which is highly active in the nervous system.
To ETNA cells, along with common apoptotic inducers, we applied neurodegenerative stimuli linked to AD and fALS in humans. In principle, in chronic neurodegenerative diseases, the apoptotic molecules play the dominant role in regulating cell dysfunction and death (see Friedlander 33 and reference therein). A spectrum of apoptosis mediators is seen in neurons vulnerable in AD and ALS post-mortem tissues. 7, 10, 34 More recently, Casp9, a component of the apoptosome, has been found to be activated in spinal motor neurons of human ALS patients and to be involved in disease progression in transgenic mouse models. 35 Cellular models mimic various aspects of the neurodegenerative diseases, none entirely recapitulating the human pathology, but most overcoming many of the limitations of human post-mortem tissues (including the nonfeasibility of manipulating mediators of apoptosis). In addition, new therapeutic nonpharmacological methodology in Parkinson's disease 36, 37 and AD 38 involves cell and synaptic renewal or replacement in order to restore the function of neuronal systems. ETNA cells exhibit properties of immature cells, including expression of proneural proteins, the ability of self-renewal and terminal differentiation. Therefore, they are an ideal model system for studying apoptosis modulation in vitro in neurodegenerative conditions, and for unravelling pathways of death in neural precursors, both of these being essential for devising novel cell therapy strategies for AD and fALS.
Materials and Methods
Plasmid constructs pRc/CMV plasmids coding for wt or G93A mutant SOD1 (wtSOD1 or G93A-SOD1, respectively) were described elsewhere. 39 Wt and mutant
Escaping apoptosis in neurodegeneration M Cozzolino et al SOD1-GFP fusion protein (wtSOD1-GFP and G93A-SOD1-GFP, respectively) expression vectors were created by PCR cloning of the SOD1 cDNAs 40 between the PmlI and PstI sites of pCMV/myc/mito/GFP (Invitrogen). This cloning step deleted the mitochondrial targeting sequence. Apaf1 expression plasmid was created by cloning of Apaf1 cDNA 3 under control of the strong promoter CAGGs (a kind gift of Dr. Miyazaki from Osaka University).
Mouse stocks and manipulation
The generation of Apaf1 À/À mice has been described previously. 3 The embryos were taken from timed matings and the day on which a vaginal plug was detected was designated as e0.5. Pregnant Apaf1 þ /-females were killed by cervical dislocation and the embryos were dissected and fixed in 4% paraformaldehyde. The embryos or mice were genotyped from extraembryonic membranes or from tail biopsies. 3 
Immunohistochemistry and RNA in situ hybridization
Immunohistochemical detection of class III b-tubulin was performed according to the manufacturer's protocol. BrdU/PBS intraperitoneal injection and detection in proliferating cells were performed as previously described. 41 The sections were counterstained with Hoechst 33258. The mean proliferation indexes (proportion of BrdU-positive nuclei to all nuclei in a section of neuroepithelium) with 7SD% have been reported (n ¼ 3). The differences between wt and Apaf1 À/À mutant values were analysed using the two-tailed Student's t-test (P40.0001). In situ hybridization on paraffin-embedded sections was also performed as previously described. 42 After staining, the embryos were embedded in paraffin and sectioned. Photographs were taken using a Zeiss-Axioskop microscope.
Cell cultures
ETNA cells were obtained as follows: control mice or timed pregnant Apaf1 þ /À female crossed with an Apaf1 þ /À male 3 were killed by decapitation at e14. The foetuses were removed and the striatum primordia from homozygous embryos ( þ / þ and À/À ) were isolated. Cells were dissociated and plated in DMEM þ 10% foetal calf serum (FCS, Invitrogen). The following day, the primary culture was infected for 24 h with filtered conditioned medium from cells packaging a retrovirus transducing the tsA58/U19 Large T Antigen and the neomycin resistance gene. 12 After infection, the virus-containing medium was replaced with fresh DMEM þ 10% FCS, and the cells kept at 331C. After 2 days, the cultures were passaged and fed with fresh complete medium in the presence of the selective agent G418 (Invitrogen) at 200 mg/ml. After selection, single colonies were picked and expanded. ETNA cells were routinely grown in DMEM þ 10% FCS, at 331C (permissive temperature for large T antigen expression) in an atmosphere of 5% CO 2 in air, and used between passages 2 and 7. Cell culture differentiation was obtained by shifting cells in growth medium containing 50 mM forskolin, 250 mM IBMX, 200 nM TPA, 10 mM dopamine and 10 ng/ml aFGF. The differentiation medium was replaced every 24 h. For the inactivation of the tsA58/U19 Large T Antigen gene expression, cells were cultured at 391C.
Transient expression of each vector (1.5 mg DNA/5-7 Â 10 5 cells) was obtained with LipofectAMINE Plus reagent (Invitrogen) according to the manufacturer's instructions. After a 3 h incubation with transfection reagents, the cells were cultured in normal growth medium for the indicated period of time. For pure cortical primary culture, e14 embryos from pregnant Apaf1 þ /À mice were killed, the cortical hemispheres were removed and neocortices were treated with 0.025% trypsin for 10 min at 371C. After centrifugation, the pellets were resuspended in MEM with 1% FCS (Invitrogen) and gently triturated. Cell suspension was centrifugated and resuspended in MEM containing 5% FCS, 5% horse serum, 2 mM Lglutamine and 25 mM glucose and plated onto polylysine-coated dishes. After 24 h, the medium was replaced with Neurobasal-A (Invitrogen) supplemented with B-27 and 1 mM glutamine. After 3 days, 10 mM cytosine arabinoside (Ara-C, SIGMA-ALDRICH) was added to inhibit nonneuronal cell proliferation. Cultures were mantained at 371C in an atmosphere of 5% CO 2 in air.
Ab peptide preparation
Ab 1-42 was purchased from PolyPeptide Laboratories GmbH. It was initially dissolved to 1 mM in hexafluoroisopropanol (HFIP, SIGMA). HFIP was then removed under vacuum and the dessicated Ab 1-42 was stored at À201C. For peptide aggregation, Ab 1-42 was dissolved to 5 mM in dimethyl sulphoxide (DMSO, SIGMA) and then brought to a final concentration of 125 mM with phenol red-free Dulbecco's medium (Invitrogen). It was incubated at 331C for 24 h and used at a final concentration of 50 mM.
Caspase activity assay and assessment of cell death
Casp3 activitiy was determined by measuring the rates of 7-amido-4-methylcoumarin (AMC) release from the synthetic caspase substrate Ac-DEVD-AMC (Calbiochem), as previously described. 43 Quantification of apoptotic cells was obtained by direct visual counting either after nuclear staining of 4% paraformaldehyde-fixed cells with the fluorescent probe Hoechst 33342 (1 mg/ml) (SIGMA-ALDRICH), or after Annexin V-FITC binding according to the manufacturer's protocol (Santa Cruz Biotechnology, Inc). In all, 100 cells were analysed in each examined field at Â 200 magnification, and eight randomly chosen fields for each experimental condition were counted. For apoptotic nuclei counting, only the cells containing clearly picnotic or fragmented nuclei were considered apoptotic. For terminal deoxynucleotidyltransferase-mediated UTP end labeling (TUNEL) assay, we used the in situ ApopTag detection kit (Intergen). TUNEL assay was carried out 48 h after transfection according to the manufacturer's protocol.
Immunoprecipitation and Western blotting
After rinsing the cultures with ice-cold PBS, cell lysis was performed in lysis buffer (20 mM Tris-HCl, pH 7.4, 1% Triton X-100, 150 mM NaCl, 1 mM EDTA, 5 mM MgCl 2 ) containing 1 mM PMSF and a protease inhibitor cocktail (SIGMA-ALDRICH). A clear supernatant was obtained by centrifugation of lysates at 17 000 Â g for 10 min. Protein content was determined using Bradford protein assay (Bio-Rad). For the detection of Apaf1 expression, 300 mg of protein was immunoprecipitated with antiApaf1 polyclonal antibody (AB16941, Chemicon Int.) coupled to protein-G-sepharose beads (SIGMA-ALDRICH). Western blots were performed on polyvinylidene difluoride membranes (Immobilon P, Millipore) as previously described (Casciati et al., 2002) . Equal loading of samples was confirmed by Ponceau red staining (SIGMA-ALDRICH). Apaf1 was detected with a rat monoclonal anti-Apaf1 antibody (clone 18H2). Immunoreactive SOD1 was detected with a sheep polyclonal antibody (Upstate biotech). Cleaved Casp3 was detected with a polyclonal antibody against the large fragment of activated Casp3 (Cell Signaling). For the detection of both full-length and cleaved active form of Casp8, the monoclonal antibody anti-Casp8 1C12 was used (Cell Signaling). Both fulllength and cleaved active fragments of Casp2 and PARP were detected with the anti-Casp2 monoclonal antibody 11B4 or with the anti-PARP rabbit polyclonal antibody (Cell Signaling), respectively. For the analysis of cytochrome c expression, the mouse monoclonal antibody anticytochrome c 7H8.2C12 (BD PharMingen) was used. To analyse the expression of cell differentiation markers, antibodies anti-NeuN (Chemicon Int.), -ChAt (Chemicon Int.), -tau (Biosource), class III b-tubulin (TUJ1, Covance Research Products) and -PSD95 (BD Biosciences) were used. Anti-b-actin antibody (clone AC15) was purchased from Sigma and antiCox IV antibody was purchased from Molecular Probes.
Subcellular fractionation
ETNA cells were harvested in hypotonic buffer (2 mM MgCl 2 , 10 mM KCl, 10 mM Tris-HCl, pH 7.6). supplemented with protease inhibitor cocktail (SIGMA) and incubated for 20 min on ice. In all, 1 V of 2 Â Mitobuffer (450 mM sucrose, 10 mM Tris-HCl, pH 7.4, 400 mM EGTA, pH 7.4, 2 mM DTT) was added and the cell suspension was homogenized for 40 strokes with a Dounce homogenizer. Samples were centrifuged twice at 900 Â g for 5 min at 41C to eliminate cell nuclei and unbroken cells. The resulting supernatant was centrifuged at 10 000 Â g for 30 min at 41C to recover the heavy-membrane pellet enriched for mitochondria, and the resulting supernatant was stored as the cytosolic fraction.
Immunocytochemistry
Cells cultured in 35 mm Petri dishes were washed in PBS and fixed with 4% paraformaldehyde in PBS for 15 min. After permeabilization with 0.2% Triton X-100 in PBS for 5 min, cells were blocked in 2% horse serum in PBS and incubated for 1 h at 371C with primary antibodies. We used an anti-cytochrome c mouse monoclonal antibody (clone 6H2.B4, BD PharMingen), an anti-cytochrome c rabbit polyclonal antibody (Santa Cruz), an anti-AIF rabbit polyclonal antibody (a generous gift of Guido Kroemer), an anti-EndoG rabbit polyclonal antibody (ProSci Incorporated), an anti-Neurofilament 160 mouse monoclonal antibody (clone NN18, SIGMA), anti-Apaf1 polyclonal antibody (AB16941, Chemicon Int.) and an anti-Large T Antigen monoclonal antibody (clone PAb419, Oncogene). Cells were then washed in blocking buffer and incubated for 1 h with labelled anti-mouse or anti-rabbit secondary antibodies (Alexa, Molecular Probes). After rinsing in blocking buffer, cell nuclei were stained with 1 mg/ ml Hoechst 33342 (SIGMA-ALDRICH) or 25 nM SYTOX (Molecular Probes) and examined under a Zeiss LSM 510 Confocal Microscopy equipped with a Â 40 objective. Fluorescence Images were adjusted for brightness, contrast and colour balance by using Adobe Photoshop 7.0.
Electron microscopy

ETNA
À/À and ETNA þ / þ cells were plated on Thermanox coverslips (Nunc), in a 24-well culture plate. After 24 h, cells were either left untransfected or transfected with G93A-SOD1 plasmid. Cells were fixed 24 h after transfection. The coverslips were treated with 1% osmium tetroxide for 90 min at 41C. Cells were washed in buffer and dehydrated in a graded ethanol series at 41C. The cell monolayers were treated with propylene oxide and then infiltrated in a mixture of epon and propylene oxide at 41C and embedded in epon for 24 h at 601C. Coverslips were removed and the adjacent surface of the epon block was cut into ultrathin sections of 85 nm with a Reichert-Jung Ultracut. Sections were collected, dried and stained with uranyl acetate and lead. The sections were observed with a LEO 906E electron microscope equipped with a HSC2 Digital Camera (Proscan). The microphotographs were acquired by Vario Vision, brought to the final size and resolution and mounted in a plate by Adobe Photoshop 7.0.
Quantitative assessment of mitochondrial impairment
Dcm was measured using TMRE (Molecular Probes) according to Waterhouse et al, 24 with minor modifications. Transfected cells were detached and incubated at 331C for 15 min in media containing TMRE (100 nM). As a control for Dcm dissipation, cells were treated with 100 nM valinomycin. TMRE fluorescence was detected by flow cytometry on a FACScan (Becton Dickinson) using FL-2. Ab 1-42 -treated or wtSOD1 and G93A-SOD1-transfected ETNA cells were also incubated with 100 nM CM-H 2 XROS (Molecular Probes), for 15 min, 331C, washed in fresh medium and then processed for immunofluorescence staining of cytochrome c as above. Measurement of cellular ATP was performed using the CytoLux kit (Perkin-Elmer) according to the manufacturer's instructions. A standard curve of known ATP concentration was used to calculate ATP concentration in the samples.
